Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $730.66 | 61 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $196.02 | 17 | $0 (2020) |
| GlaxoSmithKline, LLC. | $128.21 | 13 | $0 (2019) |
| Novo Nordisk Inc | $78.00 | 6 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $63.26 | 5 | $0 (2019) |
| Lilly USA, LLC | $55.54 | 5 | $0 (2019) |
| Astellas Pharma US Inc | $40.29 | 2 | $0 (2017) |
| Arbor Pharmaceuticals, Inc. | $30.73 | 2 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $24.09 | 2 | $0 (2020) |
| Amgen Inc. | $23.53 | 2 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $23.21 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $12.50 | 1 | Novo Nordisk Inc ($12.50) |
| 2020 | $36.22 | 3 | Novartis Pharmaceuticals Corporation ($13.28) |
| 2019 | $159.98 | 12 | PFIZER INC. ($44.67) |
| 2018 | $99.94 | 8 | Novo Nordisk Inc ($38.15) |
| 2017 | $422.02 | 37 | GlaxoSmithKline, LLC. ($116.58) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/09/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Diabetes | ||||||
| 02/26/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/06/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/29/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, STEGLATRO | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/04/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2019 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: GASTROINTESTINAL | ||||||
| 11/20/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/14/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Diabetes | ||||||
| 09/25/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Diabetes | ||||||
| 07/31/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Neuroscience | ||||||
| 07/25/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: Diabetes | ||||||
| 05/08/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 04/17/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $12.54 | General |
| Category: AED | ||||||
| 03/26/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/21/2019 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: RESPIRATORY | ||||||
| 02/22/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/12/2018 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: Diabetes | ||||||
| 11/08/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/01/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/03/2018 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Diabetes | ||||||
| 04/23/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Diabetes | ||||||
| 03/27/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/12/2018 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $10.97 | General |
| Category: Diabetes | ||||||
| 02/02/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/20/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 2,196 | 3,465 | $222,232 | $35,914 |
| 2022 | 6 | 2,315 | 3,688 | $237,511 | $40,928 |
| 2021 | 6 | 2,494 | 4,060 | $233,789 | $44,797 |
| 2020 | 10 | 2,858 | 4,900 | $262,127 | $71,142 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,627 | 2,861 | $103,104 | $16,974 | 16.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 345 | 364 | $104,468 | $16,784 | 16.1% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 80 | 81 | $3,159 | $987.49 | 31.3% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 48 | 53 | $3,180 | $450.00 | 14.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 48 | 53 | $4,293 | $385.00 | 9.0% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 48 | 53 | $4,028 | $333.50 | 8.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 366 | 389 | $111,643 | $19,838 | 17.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 1,688 | 3,031 | $109,116 | $18,636 | 17.1% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2022 | 78 | 79 | $3,081 | $1,017 | 33.0% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2022 | 61 | 63 | $3,780 | $553.41 | 14.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 61 | 63 | $5,103 | $473.52 | 9.3% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 61 | 63 | $4,788 | $410.73 | 8.6% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 387 | 403 | $97,043 | $21,391 | 22.0% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 1,843 | 3,383 | $121,788 | $20,588 | 16.9% |
| 93227 | Heart rhythm tracing, analysis, and interpretation of 48-hour ekg | Facility | 2021 | 99 | 100 | $4,530 | $1,422 | 31.4% |
| 94727 | Determination of lung volumes using gas dilution or washout | Facility | 2021 | 55 | 58 | $3,896 | $537.51 | 13.8% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2021 | 55 | 58 | $3,528 | $459.99 | 13.0% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2021 | 55 | 58 | $3,004 | $398.43 | 13.3% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 1,882 | 3,710 | $133,560 | $23,253 | 17.4% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2020 | 379 | 400 | $72,000 | $22,930 | 31.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 181 | 326 | $27,058 | $13,033 | 48.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 87 | 123 | $14,022 | $7,693 | 54.9% |
| 93227 | Heart rhythm tracing, analysis, and interpretation of 48-hour ekg | Facility | 2020 | 66 | 66 | $3,498 | $1,344 | 38.4% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2020 | 81 | 85 | $3,060 | $872.99 | 28.5% |
| 94727 | Determination of lung volumes using gas dilution or washout | Facility | 2020 | 79 | 83 | $6,308 | $807.71 | 12.8% |
About Dr. Joel Eade, MD
Dr. Joel Eade, MD is a Internal Medicine healthcare provider based in Campbellsville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1699772335.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joel Eade, MD has received a total of $730.66 in payments from pharmaceutical and medical device companies, with $12.50 received in 2021. These payments were reported across 61 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($730.66).
As a Medicare-enrolled provider, Eade has provided services to 9,863 Medicare beneficiaries, totaling 16,113 services with total Medicare billing of $192,781. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Campbellsville, KY
- Active Since 07/07/2005
- Last Updated 03/07/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1699772335
Products in Payments
- CHANTIX (Drug) $96.93
- VIAGRA (Drug) $66.41
- BREO (Drug) $64.58
- FARXIGA (Drug) $49.03
- Myrbetriq (Drug) $40.29
- TRULICITY (Drug) $33.98
- ANORO (Drug) $31.86
- INCRUSE (Drug) $31.77
- Edarbi (Drug) $30.73
- JARDIANCE (Drug) $26.69
- Ozempic (Drug) $26.48
- Victoza (Drug) $24.56
- JANUVIA (Drug) $24.09
- COLOGUARD (Device) $16.31
- Tresiba (Drug) $14.46
- LOKELMA (Drug) $14.23
- NAMZARIC (Drug) $13.42
- ENTRESTO (Drug) $13.28
- Aimovig (Biological) $13.06
- Reveal LINQ (Device) $12.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Campbellsville
Dr. Thomas Rogers, Md, MD
Internal Medicine — Payments: $2,471
Dr. David Montgomery, Md, MD
Internal Medicine — Payments: $1,558
William Feltner, D.o, D.O
Internal Medicine — Payments: $1,450
Dr. Stephen Hinton, Md, MD
Internal Medicine — Payments: $658.12
Sean Maynard, Pa-C, PA-C
Internal Medicine — Payments: $453.19
Dr. James Frank, D.o, D.O
Internal Medicine — Payments: $370.47